Novo Nordisk Diabetes Care

Novo Nordisk launches 1st GLP-1 weight pill

Novo Nordisk launches its Wegovy Pill weight-loss drug to the US market, GoodRx discounts it

Novo Nordisk has launched its first oral GLP-1 weight-loss pill in the United States, expanding beyond injectable treatments that have reshaped the obesity market.

MobiHealthNews · 10h

Novo Nordisk launches Wegovy pill, taps knownwell as NovoCare provider

Tokenist · 16h

Why Are Novo Nordisk Shares Rising in Premarket? GLP-1 Pill Launch Begins in U.S.

· 11h

Novo Nordisk Launches Daily Weight-Loss Pill to Expand GLP-1 Access

A daily pill for weight loss has officially arrived in the U.S.

· 1d

The Wegovy weight loss pill is now available in U.S.

· 11h

New weight-loss pill version of Novo Nordisk’s Wegovy is now available. Here’s how rival stocks Lilly and Viking are reacting.

· 1d

Novo Nordisk’s Wegovy Pill Now Broadly Available Across U.S.

The pill—a tablet formulation of its Wegovy shot—is now available through over 70,000 U.S. pharmacies such as CVS and Costco, and telehealth providers including Ro, LifeMD, Weight Watchers, NovoCare P...

· 1d

Novo Nordisk launches US price war over weight-loss pills

· 1d

First pill version of Wegovy for obesity launches in US

14h

Novo Nordisk: NVO Stock To $100?

Wegovy pill introduction in the U.S. may serve as the turning point that transforms a beleaguered GLP‑1 leader into a viable 2x

Hosted on MSN

Novo Nordisk’s New Study on Insulin Icodec: Implications for Diabetes Care and Market Impact

Novo Nordisk ((NVO)) announced an update on their ongoing clinical study. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Study Overview: Novo ...

Business Insider

Fangzhou, Novo Nordisk Launch Initiative for AI-Powered Diabetes and Weight Management Solutions at CIIE

SHANGHAI, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, was invited to the “Boundless Care, New Beginnings” 2025 Health Ecosystem ...

The Financial

Novo Nordisk and IBM partner to build diabetes care solutions on the Watson Health Cloud

The FINANCIAL — Novo Nordisk and IBM Watson Health on December 10 announced that the two companies will work together to create diabetes solutions built on the Watson Health Cloud. The agreement combines Novo Nordisk’s deep understanding of diabetes ...

Barron's

Novo Nordisk A/S ADR

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity ...